Quarterly Earnings

With its earnings call set for March 26, Designer Brands faces a crucial moment. Can its new strategies overcome a tough market and deliver on growth?

UiPath reports its first-ever annual profit and a new $500M buyback, but its strategic pivot to agentic AI faces scrutiny over slowing growth.

High-Trend International Group sees major profit growth from rising freight rates, but volatile market indicators and global risks present a complex voyage ahead.

Agfa-Gevaert posts strong Q4 results, but a full-year profit dip reveals a company in deep transformation, betting on digital health and green energy.

The deepwater oil and gas producer launches a major stock offering to strengthen its balance sheet, causing share dilution but aiming for long-term stability.

After a major strategic pivot, the racing game developer posts a $6.8M net income, proving the success of its focused, simulation-first approach.

After a 39% stock crash, Lakeland Industries' former CFO is sued over allegedly misleading investors about the company's deteriorating financial health.

The spice maker's upcoming Q1 report will reveal if it can manage costs, sustain consumer demand, and deliver on its ambitious 2026 growth strategy.

With a 7.7% return and 109% funded status, HOOPP secures pensions for 500,000+ healthcare workers while boosting Canada's economy.

As IZEA prepares its 2025 results, investors watch for signs of health in the booming but volatile influencer marketing industry it helped pioneer.

After a stellar 2025, Alcoa will provide critical updates on Q1 financial headwinds and its strategy for navigating a complex global aluminum market.

As price wars and new tech reshape telecom, Cogeco's CEO will outline the firm's strategy for growth, fiber expansion, and its new flanker brands.

Real estate tech firm RESAAS hires Oak Hill Financial, signaling a major push to enhance market visibility and attract investment amid a volatile stock history.

The EV maker reported a landmark non-GAAP operating profit in Q4 2025, fueled by record sales across its three brands and aggressive cost-cutting.

After 15 years without new therapies, Tonix Pharma's TONMYA enters the fibromyalgia market with a unique sublingual drug and an ambitious commercial plan.

Amid historic defense budgets, COPT Defense heads to a key conference, poised to showcase its robust financial health and critical role in national security.

Strong Q4 results and a leaner focus signal a potential turnaround for the powersports giant, but questions about cash flow remain for the road ahead.

WeRide, powered by RoboSense's advanced LiDAR, is rolling out 2,000 new Robotaxis, signaling a major shift from prototype to global mass deployment.

As electroCore preps its 2025 financial report, all eyes are on its product growth, the new Quell device, and its path to profitability in the booming bioelectronic market.

The data governance firm launches its new 'agentic' platform, aiming to free enterprises from 'pilot purgatory' by unifying data, AI, and compliance.